pyrrolidonecarboxylic acid has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjorklund, CC; Chang, CC; Feng, Y; Liao, B; O'Hare, J; Orlowski, RZ; Schally, AV; Shi, ZZ; Wang, M; Wen, J; Zu, Y | 1 |
| Kluskens, L; Köhler, H; Rudofsky, S | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and Multiple Myeloma
| Article | Year |
|---|---|
Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo.
Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Down-Regulation; Female; Gonadotropin-Releasing Hormone; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Phosphorylation; Pyrrolidonecarboxylic Acid; Transfection; Xenograft Model Antitumor Assays | 2011 |
The primary structure of a human lambda II chain.
Topics: Amino Acid Sequence; Amino Acids; Ammonium Sulfate; Carboxypeptidases; Chromatography, DEAE-Cellulose; Chymotrypsin; Electrophoresis, Polyacrylamide Gel; Freeze Drying; Humans; Immunoglobulin Fragments; Immunoglobulin lambda-Chains; Multiple Myeloma; Myeloma Proteins; Peptide Chain Termination, Translational; Peptides; Protein Conformation; Pyrrolidonecarboxylic Acid; Sodium Dodecyl Sulfate; Subtilisins; Trypsin | 1975 |